Model Portfolio Review – December 2012
The portfolios were again positive, but slightly underperforming their respective benchmarks. The fixed income funds were relative outperformers, while our equity funds, particularly the Renaissance Global Health Care Fund were laggards. Despite this recent underperformance, the risk reward metrics for the portfolios remain within expected ranges. You can download our detailed Portfolio Review...
Read MoreModel Portfolio Review – September 2012
The portfolios were again positive, but slightly underperforming their respective benchmarks. As is to be expected in a market rally, it was the Ivy Foreign Equity being the main detractor from performance in all portfolios. The fund places a big emphasis on downside protection and tends to lag in sharply rising markets. However, in volatile markets, the fund is expected to significantly...
Read MoreModel Portfolio Review – April 2012
April was not a particularly kind month to the portfolios as each portfolio lagged their respective benchmarks during the month. In all cases, this underperformance was a result of the Cundill Value Fund, which lost 6.2% during the month, underperforming the MSCI World Index by more than 4%. On a positive note, the Canadian equity funds were strong relative performers, outpacing the S&P/TSX...
Read MoreModel Portfolio Review – March 2012
March was another good month for our portfolios, with all five finishing in positive territory, and four out of the five outpacing their benchmarks. The only laggard was our Growth Portfolio which slightly underperformed its benchmark. Our Balanced Growth Portfolio posted a 1.3% gain during the month, outpacing its benchmark by 31 basis points. The biggest contributor to our outperformance was...
Read More